137 related articles for article (PubMed ID: 35666302)
21. Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.
Kodaira T; Nishimura Y; Kagami Y; Ito Y; Shikama N; Ishikura S; Hiraoka M
Jpn J Clin Oncol; 2015 Mar; 45(3):235-43. PubMed ID: 25492926
[TBL] [Abstract][Full Text] [Related]
22. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G; Gupta G; Malviya A; Saroj D
J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.
Rosario M; Francesco R; Sergio F; Niccolò GL; Alba F; Maurizio N; Sergio A; Stefania G; Filippo A
Support Care Cancer; 2016 Oct; 24(10):4451-5. PubMed ID: 27448104
[TBL] [Abstract][Full Text] [Related]
24. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
[TBL] [Abstract][Full Text] [Related]
25. Implications of Treatment Modality on Chronic Opioid Use Following Treatment for Head and Neck Cancer.
Bollig CA; Kinealy BP; Gilley DR; Clark AD; Galloway TLI; Zitsch RP; Jorgensen JB; Biedermann GB
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):799-806. PubMed ID: 32957820
[TBL] [Abstract][Full Text] [Related]
26. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
Li B; Li D; Lau DH; Farwell DG; Luu Q; Rocke DM; Newman K; Courquin J; Purdy JA; Chen AM
Radiat Oncol; 2009 Nov; 4():52. PubMed ID: 19909531
[TBL] [Abstract][Full Text] [Related]
27. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
Hamilton SN; Tran E; Berthelet E; Wu J; Olson R
Head Neck; 2018 Nov; 40(11):2432-2440. PubMed ID: 30295975
[TBL] [Abstract][Full Text] [Related]
28. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
[TBL] [Abstract][Full Text] [Related]
29. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Maguire PD; Neal CR; Hardy SM; Schreiber AM
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
[TBL] [Abstract][Full Text] [Related]
30. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
[TBL] [Abstract][Full Text] [Related]
31. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
33. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
34. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
36. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy.
Kawamura M; Yoshimura M; Asada H; Nakamura M; Matsuo Y; Mizowaki T
Radiat Oncol; 2019 Jan; 14(1):14. PubMed ID: 30665451
[TBL] [Abstract][Full Text] [Related]
37. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
38. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
39. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
40. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]